STOCK TITAN

Curtiss-Wright Corp. Form 4 Filings

CW NYSE

Every Form 4 that Curtiss-Wright Corp. (CW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CW filings page.

Rhea-AI Summary

Curtiss-Wright Corporation executive vice president and CFO K. Christopher Farkas reported a routine purchase of company stock under the employee stock purchase plan (ESPP). On 01/05/2026, he acquired 17 shares of Curtiss-Wright common stock at a price of $472.17 per share through the ESPP.

Following this transaction, he beneficially owns 4,253 shares of Curtiss-Wright common stock in direct ownership. The filing explains that under the ESPP, payroll deductions are made over a six-month offering period and used to buy shares at the end of the period, with the purchase price reflecting a 15% discount to the average selling price on 12/31/2025, the last day of that offering period.

Rhea-AI Summary

Curtiss-Wright Corporation's Chair and CEO, who also serves as a director, reported a routine share purchase under the company’s Employee Stock Purchase Plan (ESPP). On 01/05/2026, the reporting person acquired 22 shares of common stock at a price of $472.17 per share through the ESPP, which uses payroll deductions collected over a six-month offering period.

Following this transaction, the reporting person directly owns 35,251 shares of Curtiss-Wright common stock. The filing notes that the ESPP transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c), reflecting a standard employee share purchase rather than a discretionary open-market trade.

Rhea-AI Summary

Curtiss-Wright Corporation officer reports small stock sale under 10b5-1 plan

An officer of Curtiss-Wright Corporation (CW), serving as Vice President of Strategy & Business Development, reported selling 118 shares of common stock on 12/23/2025 at a price of $575 per share. After this transaction, the officer beneficially owns 3,570 shares directly.

The sale was executed under a pre-arranged Rule 10b5-1 trading plan that was adopted on August 26, 2025 and is maintained by the officer's financial advisor. The filing notes that the shares were sold in compliance with the company’s share ownership guidelines, which allow sales as long as the officer remains in compliance with those guidelines.

Rhea-AI Summary

Curtiss-Wright Corp director Peter C. Wallace reported a charitable gift of 200 shares of the company’s common stock. The transaction took place on December 11, 2025 and is coded as a bona fide gift, with a reported price of $0 because no sale occurred.

The shares were donated to a donor advised fund that will use them for charitable purposes. After this donation, Wallace beneficially owns 5,007 shares of Curtiss-Wright common stock, held directly, and he has no beneficial interest, control, or dispositive power over the gifted shares or the donor advised fund.

Rhea-AI Summary

Curtiss-Wright Corporation reported an insider stock transaction by its Chair and CEO, who is also a director. On 12/11/2025, the reporting person made a bona fide gift of 184 shares of common stock, reducing their directly held beneficial ownership to 35,229 shares. The shares were donated to a donor advised fund for charitable purposes.

According to the disclosure, the reporting person no longer has beneficial interest, control, or dispositive power over the gifted shares or the donor advised fund. The transaction was recorded as a gift with a price entry of zero, reflecting that there was no sale involved, only a transfer for charity.

Rhea-AI Summary

Curtiss-Wright Corporation director reports stock gift

A director of Curtiss-Wright Corporation reported a bona fide gift of 2,000 shares of common stock on 12/11/2025. The shares were given to irrevocable trusts established for the benefit of the reporting person’s children. Neither the reporting person nor his spouse are trustees or beneficiaries of these trusts, and the reporting person has no beneficial or pecuniary interest in the trust assets.

Following this gift, the director directly holds 13,567.85 shares of Curtiss-Wright common stock. The transaction is coded as a gift and carries a price of $0, reflecting that it was a non-cash transfer for estate or family planning purposes rather than an open-market sale.

Rhea-AI Summary

Curtiss-Wright Corporation insider transaction: A company officer, serving as Vice President of Strategy and Business Development, reported selling 175 shares of Curtiss-Wright common stock on 11/25/2025 at a price of $546.97 per share. After this sale, the reporting person beneficially owns 3,688 shares of Curtiss-Wright common stock.

The sale was executed under a pre-arranged Rule 10b5-1 trading plan that the reporting person adopted on August 26, 2025 and that is maintained by the reporting person’s financial advisor. The filing also notes that the shares were sold in compliance with the company’s share ownership guidelines, which allow sales as long as the officer remains in compliance with those ownership requirements.

Rhea-AI Summary

Curtiss-Wright Corporation (CW) Chair and CEO Lynn M. Bamford reported an open market sale of company stock. On 11/14/2025, 3,750 shares of Curtiss-Wright common stock were sold at an average price of $549.07 per share. After this transaction, the reporting person beneficially owns 35,413 shares of Curtiss-Wright common stock in direct form. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2025 and is stated to comply with the company’s share ownership guidelines.

Rhea-AI Summary

Curtiss-Wright (CW) insider transaction: Vice President and CFO K. Christopher Farkas reported an open market sale of 5,047 shares of common stock on 11/11/2025 at an average price of $577.91, coded “S.” The sale was executed under a Rule 10b5-1 trading plan adopted on August 11, 2025 and complies with the company’s share ownership guidelines.

Following the sale, the officer directly owns 4,236 shares. The filing notes the shares were sold in multiple trades within a price range of $574.14 to $579.17, and the reporting person will provide full trade details upon request.

Rhea-AI Summary

Curtiss-Wright (CW) reported an insider transaction by Chair and CEO (and Director) Lynn M. Bamford. On 11/11/2025, the reporting person sold 3,750 shares of common stock at an average price of $577.79, with trades executed between $573.46 and $577.33. Following the sale, the reporting person beneficially owns 39,163 shares directly. The sale was conducted under a Rule 10b5-1 trading plan adopted on August 12, 2025 and in compliance with the company’s share ownership guidelines.